Henry Wolff

Henry Wolff

Director/Board Member at CALITHERA BIOSCIENCES, INC.
77 year
Health Technology
Commercial Services
Consumer Services

Profile

Henry Ward Wolff is an Independent Director at Calithera Biosciences, Inc. He previously served as an Independent Director at MAP Pharmaceuticals LLC from 2008 to 2013, Sunesis Pharmaceuticals, Inc. from 2018 to 2021, and Portola Pharmaceuticals LLC from 2007 to 2020.
He was also an Executive Director at Russell Reynolds Associates, Inc. and Russell Reynolds Associates, Inc. (Germany) from 1985 to 1992.
Additionally, he held the position of Chief Financial Officer at Premenos Technology Corp.
from 1992 to 1998, Nuvelo, Inc. from 2006 to 2007, Abgenix, Inc. from 2004 to 2006, and DoubleTwist, Inc. from 1998 to 2002.
He was the Chief Financial Officer at QuantumShift, Inc. from 2002 to 2003.
Prior to that, he worked as a Senior Audit Manager at Pricewaterhouse LLP.
From 2007 to 2017, he served as the Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. Mr. Wolff obtained his undergraduate degree from the University of California, Berkeley and holds an MBA from Harvard Business School.

Henry Wolff active positions

CompaniesPositionStart
CALITHERA BIOSCIENCES, INC. Director/Board Member 02/12/2014

Former positions of Henry Wolff

CompaniesPositionEnd
VIRACTA THERAPEUTICS, INC. Director/Board Member 24/02/2021
PORTOLA PHARMACEUTICALS, INC. Director/Board Member 01/01/2020
SANGAMO THERAPEUTICS, INC. Director of Finance/CFO 01/03/2017
Director/Board Member 01/03/2013
Director of Finance/CFO 14/08/2007
See the detail of Henry Wolff's experience

Training of Henry Wolff

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Communications

Health Technology

Health Technology

Health Technology

Commercial Services

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!